|
Pérez-Andreu V, Roldán V, Antón AI, García-Barberá N, Corral J, Vicente V, González-Conejero R. Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy. Blood. 2009 May 14;113(20):4977-9. doi: 10.1182/blood-2008-09-176222. Epub 2009 Mar 6. PubMed PMID: 19270263.
AÑO: 2009; IF: 10.555
|
19270263
|
Roldán V, Ordoñez A, Marín F, Zorio E, Soria JM, Miñano A, España F, González-Conejero R, Pineda J, Estellés A, Fontcuberta J, Vicente V, Corral J. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis. Thromb Haemost. 2009 Mar;101(3):483-6. PubMed PMID: 19277409.
AÑO: 2009; IF: 4.451
|
|
Martínez C, Antón AI, Corral J, Quiroga T, Panes O, Lozano ML, González-Conejero R, Teruel R, Navarro-Núñez L, Pereira J, Mezzano D, Vicente V, Rivera J. Genotype-phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause. Br J Haematol. 2009 Jun;146(1):95-103. doi: 10.1111/j.1365-2141.2009.07713.x. Epub 2009 Apr 21. PubMed PMID: 19388931.
AÑO: 2009; IF: 4.597
|
|
González-Conejero R, Corral J, Roldán V, Vicente V. Gamma-glutamyl carboxylase R325Q polymorphism on the response of acenocoumarol. Thromb Res. 2008;122(3):429-31. doi: 10.1016/j.thromres.2007.12.007. Epub 2008 Jan 29. PubMed PMID: 18234294.
AÑO: 2008; IF: 2.449
|
|
Roldán V, Marín F, González-Conejero R, García-Honrubia A, Martí S, Alfaro A, Valdés M, Corral J, Lip GY, Vicente V. Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk. Ann Med. 2008;40(7):553-9. doi: 10.1080/07853890802108412. PubMed PMID: 18608122.
AÑO: 2008; IF: 5.435
|